Ossiam increased its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 22.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 55,378 shares of the semiconductor company's stock after buying an additional 10,084 shares during the quarter. Ossiam's holdings in Synopsys were worth $27,323,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also added to or reduced their stakes in the business. Alpine Bank Wealth Management boosted its position in Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company's stock worth $26,000 after buying an additional 25 shares during the period. TFC Financial Management Inc. increased its position in Synopsys by 1,250.0% in the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company's stock valued at $27,000 after acquiring an additional 50 shares during the period. Millstone Evans Group LLC bought a new position in shares of Synopsys during the third quarter valued at $27,000. SOA Wealth Advisors LLC. bought a new position in shares of Synopsys during the third quarter valued at $28,000. Finally, McIlrath & Eck LLC acquired a new position in shares of Synopsys during the third quarter worth $29,000. Institutional investors own 85.47% of the company's stock.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on the company. Rosenblatt Securities decreased their price objective on Synopsys from $560.00 to $530.00 and set a "buy" rating for the company in a report on Thursday, February 26th. Needham & Company LLC reaffirmed a "buy" rating on shares of Synopsys in a report on Thursday, February 26th. Wall Street Zen upgraded Synopsys from a "sell" rating to a "hold" rating in a research report on Saturday, December 13th. The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the company a "buy" rating in a research note on Wednesday, February 25th. Finally, KeyCorp lifted their price objective on Synopsys from $575.00 to $600.00 and gave the stock an "overweight" rating in a research note on Thursday, December 11th. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $531.00.
Check Out Our Latest Research Report on Synopsys
Insider Activity at Synopsys
In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the business's stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares of the company's stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider owned 11,959 shares in the company, valued at $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 4,157 shares of company stock valued at $1,945,036 in the last ninety days. 0.56% of the stock is currently owned by insiders.
Synopsys Price Performance
SNPS stock opened at $412.63 on Friday. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. The firm has a market cap of $79.04 billion, a price-to-earnings ratio of 64.07, a PEG ratio of 3.41 and a beta of 1.15. The company's fifty day simple moving average is $461.93 and its 200 day simple moving average is $464.57. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, topping analysts' consensus estimates of $3.56 by $0.21. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The firm had revenue of $2.41 billion during the quarter, compared to the consensus estimate of $2.39 billion. During the same period last year, the business posted $3.03 EPS. The business's revenue was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current year.
Synopsys Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.